Vietnam signs three COVID-19 vaccine technology transfer contracts

Vietnam has signed technology transfer contracts related to COVID-19 vaccines with partners from Russia, the US, and Japan, said Nguyen Ngo Quang, Deputy Director of the Health Ministry’s Department for Science, Technology and Training, on July 27.
Vietnam signs three COVID-19 vaccine technology transfer contracts ảnh 1Sputnik V vaccine tubes packaged at VABIOTECH (Photo: VNA)

Hanoi (VNA) - Vietnam has signed technology transfer contracts related to COVID-19 vaccines with partners from Russia, the US, and Japan, said Nguyen Ngo Quang, Deputy Director of the Health Ministry’s Department for Science, Technology and Training, on July 27.

Accordingly, one of the three was sealed between two Vietnamese companies - the Company for Vaccine and Biological Production No.1 (VABIOTECH) and the International Progressive Joint Stock Company (AIC) - and Japanese pharmaceutical firm Shionogi. VABIOTECH, a State-owned enterprise under the Ministry of Health, is one of the leading units in the field of research, manufacture and sale of vaccines and biological products for human use in the country. 

Their deal targeted the transfer of the Recombinant SARS-CoV-2 Spike Protein, a baculovirus expression vector system, with the parties signing a confidentiality agreement to access vaccine and technology records.

Regarding the technology transfer project between the AIC and Shionogi, the Ministry of Health has signed a cooperation agreement. The ministry is preparing a plan to conduct the third phase of clinical trials in Vietnam (via the National Institute of Hygiene and Epidemiology) and procedures for technology transfer (via VABIOTECH). It is expected that the vaccine will be completed and on the market in June 2022.

The second contract involving Russian Sputnik V vaccine was inked between VABIOTECH, DS-Bio, and the Russian Direct Investment Fund, with the Vietnamese side being in charge of packaging the vaccine tubes from the semi-finished products.

VABIOTECH has sent its sample tubes to Russia for quality check. After related tests finished on August 10 as scheduled, Sputnik-V vaccine tubes would be produced under the contract at a volume of 5 million doses per month. It would start with 500,000 doses in August and later scale up to 100 million doses per year.

For technology transfer projects with US partners, the Ministry of Health has sent a group of experts to coordinate with the World Health Organization (WHO) to support relevant units in completing dossiers for clinical trials phase 1-2-3 according to a shortened process, with the research expected to start on August 1 and end in late December.

The transfer and the building of a vaccine factory in Vietnam will be completed in June 2022./.
VNA

See more

Vietnamese Ambassador to Laos Nguyen Minh Tam extends greetings to leaders and staff of the Hanoi – Vientiane General Hospital on the occasion of the 71st anniversary of the Vietnamese Doctors’ Day on February 27. (Photo: VNA)

Vietnamese doctors in Laos help foster bilateral solidarity

Commending the Hanoi – Vientiane General Hospital’s 13-year development, Ambassador Nguyen Minh Tam noted that prioritising conscience and virtue has helped it build a strong reputation among Lao citizens, the Vietnamese community and international friends in Laos.

Organ transplantation at the University Medical Centre Ho Chi Minh City (Photo: the University Medical Centre Ho Chi Minh City)

Professional excellence, dedication define Vietnam’s healthcare system

When patients pull through from the brink of death, when their vital signs stabilise and transplanted hearts begin beating strongly in new bodies, the joy shared by the entire medical team is overwhelming. And when the country welcomes the New Year, saving lives takes on an even more profound significance — offering patients and their families a new spring of hope.

At Phu Rieng communal medical station in Dong Nai province (Photo: VNA)

Vietnam fosters maternal and child healthcare, advances toward 2035 goals

The under-five mortality rate in Vietnam in 2025 was estimated at below 16 per 1,000 live births, more than three times lower than the 1990 level. The infant mortality rate (under one year) declined fourfold to below 11 per 1,000, while the neonatal mortality rate dropped fivefold, from 44 per 1,000 in 1990 to 8.8 per 1,000 in 2025.

Medicine support programmes provide significant benefits to patients throughout their course of treatment. (Photo: VNA)

Over 6,000 patients receive free medicines

The schemes focus primarily on cancer, rare diseases and severe chronic conditions, areas where treatment costs are high and often require expensive biological and originator drugs.

A lung transplant surgery at the National Lung Hospital (Photo: VNA)

Vietnam reaches new height in organ transplantation

From demanding cross-country transplants to highly specialised procedures nearing regional and international standards, the sector has created new chances of survival for thousands of patients. However, persistent bottlenecks in organ donation and the legal framework highlight the urgent need to further perfect the national donation–transplantation system. In the era of advanced medicine, progress is measured not only by surgical mastery, but also by the ability to turn loss into hope and sustain life.

The DAV asks pharmacy producers and distributors to increase medicine supply capacity during Tet to meet increasing demand (Photo: VNA)

Measures rolled out to ensure adequate medicine supply during Tet

Accordingly, provincial and municipal health departments are required to direct hospitals, centres for disease control and health care facilities to urgently develop plans and carry out medicine procurement to ensure sufficient supply, absolutely avoiding shortages. Medicines must meet quality standards and be sold at reasonable prices, with no sudden price increases allowed.

Military doctors conduct ultrasound examinations for residents in Dong Dang town, Cao Loc district, Lang Son province. (Photo: VNA)

Resolution 72 opens path to a modern, sustainable healthcare system

To build a resilient healthcare system capable of meeting the challenges of ageing, emerging diseases and rising expectations for quality care, Vietnam must continue to strengthen primary and preventive care, invest in human resources, accelerate digitalisation and big data development, and refine healthcare financing mechanisms.

Vietnam steps up Nipah virus prevention at border gates (Photo: suckhoedoisong.vn)

Vietnam tightens Nipah virus prevention at border gates

Local authorities have been instructed to strengthen disease prevention and control measures at border gates, medical facilities and in the community, stay updated with global disease information, and closely monitor inbound travellers.

Nipah virus infection is designated a Group A infectious disease, with reported fatality rates of between 40 and 75%. (Photo: moh.gov.vn)

Health sector steps up preparedness against Nipah virus disease

Nipah virus infection is designated a Group A infectious disease, with reported fatality rates of between 40 and 75%. At present, no vaccine or specific antiviral treatment is available. The virus is mainly transmitted from animals to humans or through contact with contaminated food and objects, and can also spread between people via direct contact with bodily fluids and secretions of infected patients.

Member of the Party Central Committee and Minister of Health Dao Hong Lan (Photo: VNA)

Health minister highlights comprehensive, people-centred healthcare orientation

Member of the Party Central Committee and Minister of Health Dao Hong Lan said the Politburo's Resolution No. 72 provides a breakthrough orientation for the protection, care and improvement of the people’s health. It places the people’s health at the centre of all healthcare policies and services, while aiming to address long-standing bottlenecks in the health sector that have yet to be fundamentally resolved.

Elderly people do morning exercises in the Hoan Kiem Lake area in Hanoi. (Photo: VNA)

Strategic roadmap for healthier future

As Vietnam’s population ages rapidly, Dr Angela Pratt, WHO Representative in Vietnam, identified two strategic priorities: strengthening primary healthcare and developing a formal long-term care system. These measures are essential not only for healthy ageing, but also as long-term investments with wide-ranging socio-economic returns.